Quite possible but personally I won’t be getting hung up on it if it isn’t. The fact that the option for GVHD will be signed, is going to be fantastic for the company and the validation it will show to the rest of the biotech industry. Hopefully management at least make an attempt to inform the wider market better than they have in the past. A full page spread in the AFR next week would be a good starting point.
Going forward..., page-1114
-
- There are more pages in this discussion • 85 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
21.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $34.32M | |||
| Open | High | Low | Value | Volume |
| 21.5¢ | 21.5¢ | 21.5¢ | $5.375K | 25K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 27580 | 21.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.0¢ | 41728 | 1 |
View Market Depth
| Last trade - 12.20pm 29/11/2024 (20 minute delay) ? |
| CYP (ASX) Chart |
